Roches Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-India

Casirivimab and Imdevimab is indicated for restricted use in emergency situation for the treatment of mild to moderate COVID-19 in patients who are at high risk of severe Covid.

from India Infoline News Service https://ift.tt/349ojTw

Comments